Вирус иммунодефицита кошек: литература
Carpenter MA, O'Brien MA: Coadaptation and immunodeficiency virus: Lessons from the Felidae. Curr Opin Genet Dev 5:739,1995. Review of the coadaptation of host and virus at the individual and population level, in disease outbreaks, and during spread to related host species.
English RV, Nelson P, Johnson CM, et al: Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 170:543, 1994. A prospective study of the longterm disease expression of random source and SPF cats during FIV infection.
Hartmann K, Donath A, Beer B, et al: Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol 35:167, 1992. A double-blind, placebo-controlled clinical trial of AZT and 9-(2-phosphonylmethoxyethyl) adenine (PMEA) treatment of 33 clinically ill FIV-infected cats.
Proceedings of the Third International Feline Retrovirus Research Symposium, Fort Collins, Co, March 6-9,1996. Abstracts of 99 current worldwide research projects on the epidemiology, virology, immunology,pathogenesis, treatment, and prevention of FIV infection.
Proceedings of the Fourth International Feline Retrovirus Research Symposium, Glasgow, Scotland, May 28-30, 1998. Abstracts of 81 international research projects on FIV and FeLV.
Reubel GH, Dean GA, George JW, et al: Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats. J Acquir Immune Dene Syndr 7:1003, 1994. Virologic and immunologic response during immune stimulation of FIV-infected cats and the relationship to progression of clinical disease.
